Rapid Micro Biosystems Announces Review of Strategic Alternatives to Maximize Shareholder Value
August 12, 2022 07:00 ET
|
Rapid Micro Biosystems, Inc.
Rejects Unsolicited, Non-Binding Proposal from Kennedy Lewis Investment Management Adopts Limited Duration Stockholder Rights Plan LOWELL, Mass., Aug. 12, 2022 (GLOBE NEWSWIRE) -- Rapid Micro...
Rapid Micro Biosystems Provides Business Update and Reports Second Quarter 2022 Financial Results
August 12, 2022 07:00 ET
|
Rapid Micro Biosystems, Inc.
Reports second quarter 2022 commercial revenue of $3.9 million Lowers full year 2022 commercial revenue guidance to at least $17.0 million Implements organizational restructuring plan to right-size...
Rapid Micro Biosystems to Announce Second Quarter 2022 Financial Results on August 12, 2022
August 09, 2022 08:00 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems Confirms Receipt of Unsolicited, Non-Binding Proposal from Kennedy Lewis Investment Management
June 30, 2022 14:33 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., June 30, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems Reports First Quarter 2022 Financial Results
May 10, 2022 06:00 ET
|
Rapid Micro Biosystems, Inc.
Reports first quarter 2022 commercial revenue of $4.2 million Reaffirms full year 2022 commercial revenue outlook range of $27 million to $32 million, representing growth of approximately 25% to...
Rapid Micro Biosystems to Announce First Quarter 2022 Financial Results on May 10, 2022
April 26, 2022 16:10 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., April 26, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2021 Financial Results and Reaffirms Full Year 2022 Guidance
March 04, 2022 06:00 ET
|
Rapid Micro Biosystems, Inc.
Reports fourth quarter 2021 total revenue of $5.2 million and commercial revenue of $4.9 million Reports full year 2021 total revenue of $23.2 million and commercial revenue of $21.6 million ...
Rapid Micro Biosystems to Participate at the Cowen 42nd Annual Health Care Conference
February 23, 2022 16:45 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2021 Financial Results on March 4, 2022
February 17, 2022 16:10 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“Rapid Micro” or the “Company”), an innovative life sciences technology company providing mission...
Rapid Micro Biosystems Appoints Michael Beaulieu as Vice President, Investor Relations and Corporate Communications
January 20, 2022 16:30 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...